Standards & Regulation

Claus Zieler from Astellas and EFPIA addresses the challenges facing innovation in Europe, including regulatory burdens and access to medicines.

We dive into the archive of 2018 for insight and inspiration – this time with Bruno Sepodes

Counterfeit medicines pose a significant threat to global health. A recent study uncovers alarming facts and emphasizes the need for solutions.

How the pharma industry can help tackle the opioid crisis and advance treatments

Here’s a look at recent violations cited in FDA Warning Letters: fly pupae, cross contamination, trial dosing errors, and more.

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.

The deadline for the US Drug Supply Chain Security Act is approaching.

Drug shortages are everywhere. We speak with Vimala Raghavendran at the US Pharmacopeia to get the full picture.

With open minds and open sources, the future is foundational – and bright.